RT-PCR analysis confirmed that miR-429, as well as miR-190 and miR-584, are differentially expressed in both HER2+ BC cell lines, and in human HER2+ BC tissues (miR-190 and miR-584 downregulated and miR-429 upregulated). Here, ERBB2 is linked to breast cancer.